Systematic analysis of loss-of-function variants across MODY genes demonstrates gene- and NMD-specific effects and identifies NMD-escape INS variants as a novel cause of MODY
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Aims/hypothesis
Accurate interpretation of loss-of-function (LOF) variants in MODY genes is essential for diagnosis but remains challenging, particularly for variants predicted to escape nonsense-mediated decay (NMD). We aimed to systematically evaluate the pathogenicity of LOF variants, stratified by NMD-triggering and NMD-escape status, across all known MODY genes.
Methods
We analysed ultra-rare LOF variants (minor allele frequency <1 in 10,000) in 5171 individuals of European ancestry with suspected MODY, compared with 155,501 population-based controls from UK Biobank. LOF variants in ABCC8, GCK, HNF1A, HNF4A, HNF1B, INS, KCNJ11, NEUROD1, PDX1 , and RFX6 were classified as NMD-triggering or NMD-escape. We tested for gene-level enrichment in cases versus controls. For novel associations, we performed replication in additional MODY cases, assessed familial co-segregation, and undertook in-silico protein modelling.
Results
LOF variants were significantly enriched in all MODY genes except ABCC8 and KCNJ11 . Both NMD-triggering and NMD-escape variants were enriched in GCK, HNF1A , and HNF4A , consistent with haploinsufficiency (all P <10 -3 ). HNF1B and RFX6 showed enrichment only for NMD-triggering variants, while NEUROD1 and PDX1 were enriched for only NMD-escape variants.
A novel finding was significant enrichment of only NMD-escape LOF variants in INS (OR = 181, P < 10 -5 ). Including replication, we identified eight families with 17 affected individuals carrying INS variants. These variants co-segregated with diabetes (LOD score = 3), included one de novo case, and were absent from >800,000 population controls. Individuals presented with diabetes at a median age of 19 years, had median BMI of 22.9 kg/m 2 , were negative for islet autoantibodies, and had low type 1 diabetes genetic risk scores. Compared with INS missense MODY, diagnosis occurred ∼10 years later. Protein modelling suggested that INS NMD-escape variants produce aberrant proinsulin molecules with unpaired B chain cysteines, leading to milder misfolding.
Conclusions/interpretation
The pathogenicity of LOF variants in MODY genes depends on gene context and NMD status. Heterozygous NMD-escape LOF variants in INS are a novel cause of MODY. These findings provide systematic gene-level evidence to inform variant interpretation guidelines and improve the accuracy of MODY diagnosis in clinical practice.
Research in Context
What is already known about this subject?
-
Interpretation of loss-of-function (LOF) variants is complex and strongly influenced by predicted NMD status.
-
Current evidence for LOF variants in MODY genes is mainly based on case reports.
-
Systematic genetic evidence is needed to improve diagnosis and to inform gene-specific variant interpretation guidelines.
What is the key question?
-
Do NMD-triggering and NMD-escape LOF variants contribute to MODY across all known MODY genes?
What are the new findings?
-
Heterozygous NMD-escape LOF variants in INS are a novel cause of MODY.
-
Heterozygous LOF variants in ABCC8 and KCNJ11 are not enriched in MODY.
-
Enrichment of NMD-triggering and NMD-escape LOF variants differs across MODY genes, clarifying underlying mechanisms and supporting gene-specific interpretation.
How might this impact on clinical practice in the foreseeable future?
-
These results improve the accuracy of MODY diagnosis by providing robust evidence for variant interpretation and supporting gene-specific clinical guidelines.